Description
Pharmacological action
Scope – orthopedics, rheumatology, traumatology, surgery, sports medicine.
Armaviscon Plus is a protector of synovial fluid of the joint. It is used against the background of degenerative changes in the surface of the synovial cartilage to improve joint mobility, reduce pain, reduce inflammatory reactions and restore homeostasis in the cartilage.
Properties and efficacy:
The product has an analgesic, corrective effect on the metabolism of bone and cartilage.
Armaviscon Plus is a sterile viscous solution of sodium salt of hyaluronic acid (sodium hyaluronate) with a high degree of purification, high molecular weight.
Hyaluronic acid – a necessary component of the extracellular matrix, is present in high concentrations in the composition of cartilage and synovial fluid. Hyaluronic acid provides the viscosity and elasticity of the synovial fluid, and it is also necessary for the formation of cartilage. With osteoarthritis, deficiency and qualitative changes in hyaluronic acid in the composition of synovial fluid and cartilage are noted. Intra-articular administration of hyaluronic acid leads to an improvement in the functional state of the joint.
When using Armaviscon Plus for osteoarthritis of the knee, there is an improvement in the clinical course of osteoarthritis up to six months from the time of use, there is an anti-inflammatory and analgesic effect due to replenishment of the volume and restoration of the viscosity and elasticity of the synovial fluid, which fills the joint cavity and acts as an intraarticular lubricant. It prevents the friction of articular surfaces, which eliminates pain and inflammation. It also protects against premature wear and destruction of hyaline cartilage, provides mobility, and has cushioning capabilities (dampens external shocks, protecting joint components from damage).
Hyaluronate sodium solution is distributed topically in the joint cavity, where it undergoes local transformations, providing a lubricating effect. Removing or replacing the product is not applicable, since it is inextricably mixed with synovial fluid of the joint.
Indications
To increase joint mobility and eliminate pain caused by degenerative-dystrophic or post-traumatic joint changes
For rehabilitation after arthroscopy
For the treatment of patients with increased physical activity and regularly loading the affected joint.
Contraindications
Use during pregnancy and during breastfeeding:
It is not recommended to use the product during pregnancy and during breastfeeding due to lack of clinical data. Prescribing during pregnancy and during breastfeeding at the discretion of the orthopedic surgeon. Contraindications:
hypersensitivity to the components of the
agent, the presence of infection or damage to the skin at the injection site
acute synovitis
children under 18 years of age (due to lack of clinical data).
Special instructions
Do not use Armaviscon Plus with damaged or opened packaging.
Sodium hyaluronate obtained by fermentation of bacteria Streptococcus equi and thoroughly cleaned. However, the doctor must consider the potential risk associated with the injection of any biological substance.
Extraarticular injection of Armaviscon Plus into the joint capsule or synovial tissue is not permitted. This can cause local side effects.
Do not allow the product to enter the blood vessels. During the first 2 days after the procedure, it is recommended not to overload the joint, especially prolonged loading should be avoided.
Armaviscon Plus does not affect a person ² ¢s ability to drive vehicles, engage in other potentially dangerous activities, requiring increased concentration of attention and speed of psychomotor reactions.
Patients with inflammatory diseases, in particular, with ankylosing spondylitis and rheumatoid arthritis, Armaviscon Plus is not prescribed.
Not intended for children.
For single use only.
For the safe use and disposal of used needles, comply with national and regional rules and regulations.
Requirements for the use and operation of a medical device:
The product is intended for single and single use.
Carrying out procedures with this medical device requires special training and special skills and is intended for use in medical institutions.
Composition
-16.5 mg / ml (1.5%),
sodium chloride – 8.50 mg / ml,
sodium hydrogen phosphate dihydrate – 0.22 mg / ml,
sodium dihydrogen phosphate dihydrate – 0.044 mg / ml,
water for injection – up to 1 ml.
Side effects
Moderate soreness, swelling, fever and redness in the injection area, an increase in the content of exudate in the joint cavity.
The above symptoms are transient in nature and usually disappear after 24 hours. If these symptoms occur, it is recommended to relieve the affected joint and apply ice. Very rarely, allergic reactions can be observed.
Storage conditions
Store at a temperature of + 2 ° C to + 25 ° C. Do not freeze.
Active ingredient
Sodium hyaluronate
S11lf69 pharmacy delivery terms
Prescription
Dosage form
solution for injection
